BioCentury
ARTICLE | Clinical News

Quadra-Logic Technologies Inc. regulatory update

April 18, 1994 7:00 AM UTC

Quadra-Logic Technologies Inc. (QLTIF) The Vancouver company submitted an NDA and three PMAs to the FDA for approval to market Photofrin, its light-activated drug, as a palliative treatment for parti...